BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

258 related articles for article (PubMed ID: 20639355)

  • 1. Metformin and placebo therapy both improve weight management and fasting insulin in obese insulin-resistant adolescents: a prospective, placebo-controlled, randomized study.
    Wiegand S; l'Allemand D; Hübel H; Krude H; Bürmann M; Martus P; Grüters A; Holl RW
    Eur J Endocrinol; 2010 Oct; 163(4):585-92. PubMed ID: 20639355
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Long-term treatment with metformin in obese, insulin-resistant adolescents: results of a randomized double-blinded placebo-controlled trial.
    van der Aa MP; Elst MA; van de Garde EM; van Mil EG; Knibbe CA; van der Vorst MM
    Nutr Diabetes; 2016 Aug; 6(8):e228. PubMed ID: 27571249
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Metformin for overweight women at midlife: a double-blind, randomized, controlled trial.
    Worsley R; Jane F; Robinson PJ; Bell RJ; Davis SR
    Climacteric; 2015 Apr; 18(2):270-7. PubMed ID: 25333776
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Prevalence of the metabolic syndrome in Zhejiang Chinese obese children and adolescents and the effect of metformin combined with lifestyle intervention.
    Fu JF; Liang L; Zou CC; Hong F; Wang CL; Wang XM; Zhao ZY
    Int J Obes (Lond); 2007 Jan; 31(1):15-22. PubMed ID: 16953257
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Metformin improves polycystic ovary syndrome symptoms irrespective of pre-treatment insulin resistance.
    Tan S; Hahn S; Benson S; Dietz T; Lahner H; Moeller LC; Schmidt M; Elsenbruch S; Kimmig R; Mann K; Janssen OE
    Eur J Endocrinol; 2007 Nov; 157(5):669-76. PubMed ID: 17984248
    [TBL] [Abstract][Full Text] [Related]  

  • 6. The effects of metformin on body mass index and glucose tolerance in obese adolescents with fasting hyperinsulinemia and a family history of type 2 diabetes.
    Freemark M; Bursey D
    Pediatrics; 2001 Apr; 107(4):E55. PubMed ID: 11335776
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Omega-3 polyunsaturated fatty acids reduce insulin resistance and triglycerides in obese children and adolescents.
    Juárez-López C; Klünder-Klünder M; Madrigal-Azcárate A; Flores-Huerta S
    Pediatr Diabetes; 2013 Aug; 14(5):377-83. PubMed ID: 23438101
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Effect of long-term treatment with metformin added to hypocaloric diet on body composition, fat distribution, and androgen and insulin levels in abdominally obese women with and without the polycystic ovary syndrome.
    Pasquali R; Gambineri A; Biscotti D; Vicennati V; Gagliardi L; Colitta D; Fiorini S; Cognigni GE; Filicori M; Morselli-Labate AM
    J Clin Endocrinol Metab; 2000 Aug; 85(8):2767-74. PubMed ID: 10946879
    [TBL] [Abstract][Full Text] [Related]  

  • 9. The effects of metformin on inflammatory mediators in obese adolescents with insulin resistance: controlled randomized clinical trial.
    Evia-Viscarra ML; Rodea-Montero ER; Apolinar-Jiménez E; Muñoz-Noriega N; García-Morales LM; Leaños-Pérez C; Figueroa-Barrón M; Sánchez-Fierros D; Reyes-García JG
    J Pediatr Endocrinol Metab; 2012; 25(1-2):41-9. PubMed ID: 22570949
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Randomized, controlled trial of metformin for obesity and insulin resistance in children and adolescents: improvement in body composition and fasting insulin.
    Srinivasan S; Ambler GR; Baur LA; Garnett SP; Tepsa M; Yap F; Ward GM; Cowell CT
    J Clin Endocrinol Metab; 2006 Jun; 91(6):2074-80. PubMed ID: 16595599
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Lifestyle intervention and metformin for treatment of antipsychotic-induced weight gain: a randomized controlled trial.
    Wu RR; Zhao JP; Jin H; Shao P; Fang MS; Guo XF; He YQ; Liu YJ; Chen JD; Li LH
    JAMA; 2008 Jan; 299(2):185-93. PubMed ID: 18182600
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Use of metformin in obese adolescents with hyperinsulinemia: a 6-month, randomized, double-blind, placebo-controlled clinical trial.
    Atabek ME; Pirgon O
    J Pediatr Endocrinol Metab; 2008 Apr; 21(4):339-48. PubMed ID: 18556965
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Effects of lifestyle intervention and metformin on weight management and markers of metabolic syndrome in obese adolescents.
    Harden KA; Cowan PA; Velasquez-Mieyer P; Patton SB
    J Am Acad Nurse Pract; 2007 Jul; 19(7):368-77. PubMed ID: 17680902
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Variation in inflammatory markers and glycemic parameters after 12 months of exenatide plus metformin treatment compared with metformin alone: a randomized placebo-controlled trial.
    Derosa G; Franzetti IG; Querci F; Carbone A; Ciccarelli L; Piccinni MN; Fogari E; Maffioli P
    Pharmacotherapy; 2013 Aug; 33(8):817-26. PubMed ID: 23744726
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Effects of metformin on body weight and body composition in obese insulin-resistant children: a randomized clinical trial.
    Yanovski JA; Krakoff J; Salaita CG; McDuffie JR; Kozlosky M; Sebring NG; Reynolds JC; Brady SM; Calis KA
    Diabetes; 2011 Feb; 60(2):477-85. PubMed ID: 21228310
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Long-term metformin treatment in adolescents with obesity and insulin resistance, results of an open label extension study.
    Lentferink YE; van der Aa MP; van Mill EGAH; Knibbe CAJ; van der Vorst MMJ
    Nutr Diabetes; 2018 Sep; 8(1):47. PubMed ID: 30197416
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Fasting serum insulin and the homeostasis model of insulin resistance (HOMA-IR) in the monitoring of lifestyle interventions in obese persons.
    Vogeser M; König D; Frey I; Predel HG; Parhofer KG; Berg A
    Clin Biochem; 2007 Sep; 40(13-14):964-8. PubMed ID: 17583689
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Effect of lifestyle modification and metformin therapy on emerging cardiovascular risk factors in overweight Indian women with polycystic ovary syndrome.
    Rajagopal G; Reddy AP; Venkata Harinarayan C; Suresh V; Bitla A; P V L N Rao S; Sachan A
    Metab Syndr Relat Disord; 2012 Aug; 10(4):273-9. PubMed ID: 22468948
    [TBL] [Abstract][Full Text] [Related]  

  • 19. A randomized, double-blind, placebo-controlled trial of metformin treatment of weight gain associated with initiation of atypical antipsychotic therapy in children and adolescents.
    Klein DJ; Cottingham EM; Sorter M; Barton BA; Morrison JA
    Am J Psychiatry; 2006 Dec; 163(12):2072-9. PubMed ID: 17151157
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Metformin in obese children and adolescents: the MOCA trial.
    Kendall D; Vail A; Amin R; Barrett T; Dimitri P; Ivison F; Kibirige M; Mathew V; Matyka K; McGovern A; Stirling H; Tetlow L; Wales J; Wright N; Clayton P; Hall C
    J Clin Endocrinol Metab; 2013 Jan; 98(1):322-9. PubMed ID: 23175691
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 13.